MIVACRON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Mivacron, and what generic alternatives are available?
Mivacron is a drug marketed by Abbvie and is included in one NDA.
The generic ingredient in MIVACRON is mivacurium chloride. There are two drug master file entries for this compound. Additional details are available on the mivacurium chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mivacron
A generic version of MIVACRON was approved as mivacurium chloride by WOODWARD on October 12th, 2021.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MIVACRON?
- What are the global sales for MIVACRON?
- What is Average Wholesale Price for MIVACRON?
Summary for MIVACRON
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 47 |
Clinical Trials: | 5 |
Patent Applications: | 622 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for MIVACRON |
DailyMed Link: | MIVACRON at DailyMed |
![MIVACRON drug patent expirations Drug patent expirations by year for MIVACRON](/p/graph/s/t/MIVACRON-patent-expirations.png)
![Drug Prices for MIVACRON](/p/graph/drug-price/MIVACRON.png)
Recent Clinical Trials for MIVACRON
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Université Libre de Bruxelles | N/A |
University Hospital Ostrava | N/A |
Tang-Du Hospital | Phase 2 |
US Patents and Regulatory Information for MIVACRON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | MIVACRON | mivacurium chloride | SOLUTION;INTRAVENOUS | 020098-001 | Jan 22, 1992 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Abbvie | MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER | mivacurium chloride | INJECTABLE;INJECTION | 020098-002 | Jan 22, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Abbvie | MIVACRON | mivacurium chloride | SOLUTION;INTRAVENOUS | 020098-004 | Jan 22, 1992 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MIVACRON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | MIVACRON | mivacurium chloride | SOLUTION;INTRAVENOUS | 020098-001 | Jan 22, 1992 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MIVACRON
See the table below for patents covering MIVACRON around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 4510885 | ⤷ Sign Up | |
Monaco | 1690 | ⤷ Sign Up | |
Latvia | 5483 | Izohinolinija atvasinajumu iegusanas panemiens | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for MIVACRON
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0181055 | 96C0001 | Belgium | ⤷ Sign Up | PRODUCT NAME: MIVACURIUM CHLORID.= MIVACURIUM (+5% OVERDOSERING); NAT REG.: 251 IS 152 F 12 19951114; FIRST REG.: GB 0003/0325 19921208 |
0181055 | SPC/GB93/031 | United Kingdom | ⤷ Sign Up | SPC/GB93/031:, EXPIRES: 20071207 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |